Chinese Rapid Test Kits Suppliers and Manufacturers

Product name:Canine Pregnancy@Relaxin Rapid Test (Relaxin) MOQ: 1PCS Use: Vet Diagnosis Assay Time:  5 - 10 minutes Shelf life: 18-24 Months Specimen: Serum Plasma Feces, vomit Sensitivity: 99.8% Storage: 2-30 Degree Certification: ISO9001 Packing: 10pcs/box

Product name:Giardia Antigen Rapid Test (Giardia Ag) MOQ: 1PCS Use: Vet Diagnosis Assay Time:  5 - 10 minutes Shelf life: 18-24 Months Specimen: Serum Plasma Feces, vomit Sensitivity: 99.8% Storage: 2-30 Degree Certification: ISO9001 Packing: 10pcs/box

The Canine Parvo Virus Antigen Rapid Test is a lateral flow immunochromatographic assay for the qualitative detection of canine Parvo virus antigen (CPV Ag) in dogs feces or vomit specimen. Assay Time: 5-10 minutes The Canine Parvo Virus Antigen Rapid Test is based on sandwich lateral flow immunochromatographic assay. The test device has a testing window for the observation of assay running and result reading. The testing window has an invisible T (test) zone and a C (control) zone before running the assay. When the treated sample was applied into the sample hole on the device, the liquid will laterally flow through the surface of the test strip and react with the pre-coated monoclonal antibodies. If there is CPV antigen in the specimen, a visible T line will appear. The C line should always appear after a sample is applied, which indicates a valid result. By this means, the device can accurately indicate the presence of Parvo virus antigen in the specimen. REAGENTS AND MATERIALS -Test devices, with disposable droppers -Assay buffer -Cotton swabs -Products Manual STORAGE AND STABILITY The kit can be stored at room temperature (4-30C). The test kit is stable through the expiration date marked on the package label. DO NOT FREEZE. Do not store the test kit in direct sunlight. TEST PROCEDURE -Collect dogs fresh feces or vomit with the cotton swab from dogs anus or from the ground. -Insert the swab into the provided assay buffer tube. Agitates it to get efficient sample extraction. -Take out the test device from the foil pouch and place it horizontally. -Suck the treated sample extraction from the assay buffer tube and place 3 drops into the sample hole â??Sâ?? of the test device. -Interpret the result in 5-10 minutes. Result after 10 minutes is considered as invalid. INTERPRETATION OF RESULTS -Positive (+): The presence of both â??Câ?? line and zone â??Tâ?? line, no matter T line is clear or vague. -Negative (-): Only clear C line appear. No T line. -Invalid: No colored line appears in C zone. No matter if T line appears. PRECAUTIONS -All reagents must be at room temperature before running the assay. -Do not remove test cassette from its pouch until immediately before use. -Do not use the test beyond its expiration date. -The components in this kit have been quality control tested as standard batch unit. Do not mix components from different lot numbers. -All specimens are of potential infection. It must be strictly treated according to the rules and regulations by local states. LIMITATION Canine Parvo Virus Antigen Rapid Test is for in vitro veterinary diagnosis use only. All result should be considered with other clinical information available with veterinarian. It is suggested to apply a further confirmative method when positive result was observed.

The Canine Parvo Virus Antigen Rapid Test is a lateral flow immunochromatographic assay for the qualitative detection of canine Parvo virus antigen (CPV Ag) in dogâ??s feces or vomit specimen. Assay Time: 5-10 minutes The Canine Parvo Virus Antigen Rapid Test is based on sandwich lateral flow immunochromatographic assay. The test device has a testing window for the observation of assay running and result reading. The testing window has an invisible T (test) zone and a C (control) zone before running the assay. When the treated sample was applied into the sample hole on the device, the liquid will laterally flow through the surface of the test strip and react with the pre-coated monoclonal antibodies. If there is CPV antigen in the specimen, a visible T line will appear. The C line should always appear after a sample is applied, which indicates a valid result. By this means, the device can accurately indicate the presence of Parvo virus antigen in the specimen. REAGENTS AND MATERIALS -Test devices, with disposable droppers -Assay buffer -Cotton swabs -Products Manual STORAGE AND STABILITY The kit can be stored at room temperature (4-30�°C). The test kit is stable through the expiration date marked on the package label. DO NOT FREEZE. Do not store the test kit in direct sunlight. TEST PROCEDURE -Collect dogâ??s fresh feces or vomit with the cotton swab from dogâ??s anus or from the ground. -Insert the swab into the provided assay buffer tube. Agitates it to get efficient sample extraction. -Take out the test device from the foil pouch and place it horizontally. -Suck the treated sample extraction from the assay buffer tube and place 3 drops into the sample hole â??Sâ?? of the test device. -Interpret the result in 5-10 minutes. Result after 10 minutes is considered as invalid. INTERPRETATION OF RESULTS -Positive (+): The presence of both â??Câ?? line and zone â??Tâ?? line, no matter T line is clear or vague. -Negative (-): Only clear C line appear. No T line. -Invalid: No colored line appears in C zone. No matter if T line appears. PRECAUTIONS -All reagents must be at room temperature before running the assay. -Do not remove test cassette from its pouch until immediately before use. -Do not use the test beyond its expiration date. -The components in this kit have been quality control tested as standard batch unit. Do not mix components from different lot numbers. -All specimens are of potential infection. It must be strictly treated according to the rules and regulations by local states. LIMITATION Canine Parvo Virus Antigen Rapid Test is for in vitro veterinary diagnosis use only. All result should be considered with other clinical information available with veterinarian. It is suggested to apply a further confirmative method when positive result was observed.

Strengths of antigen rapid test: FAST & EASY (Compared with PCR test) People could RAPIDLY & EASILY be tested as a prerequisite to school attendance, work, or travel. FAST --PCR test - the swab test looks for viral RNA - may take days to perform. --Antigen test might take only 15-30 minutes to complete. EASY --PCR test swabs must be sent to laboratory to be performed by experienced technicians, it requires expensive and specialized equipment and can take days to get result. -- Antigen test can be run in an office or at home in about 15-30 minutes. The sampling process is FAST & EASY and requires very little expertise. Similar tests are done routinely in clinics for influenza all the time.

For in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasal (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days after onset of symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, not for at-home testing. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or 2019-nCoV) is an enveloped non-segmented positive-sense RNA virus. It is the cause of coronavirus disease (COVID-19), which is contagious in humans. SARS-CoV-2 has several structural proteins including spike (S), envelope (E), membrane (M), and nucleocapsid (N). The antigen is generally detectable in upper respiratory samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out a bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, which do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. For in vitro diagnostic use only. For professional use only .

COVID-19 (2019-nCoV) Coronavirus IgG/IgM Rapid Test Kit Principle: based on Colloidal Gold Method, to detect COVID-19 IgG/IgM Antibody in serum, plasma, whole blood qualitatively. Easy to operate, results can be obtained in 15 minutes. Component: 25 tests cassttes/ 25 dropper/ 25 tubes of dilution buffer/25 Alcohol pad/ 25 Lancet/ 1 manual Certificate: CE, ISO13485, ISO9001

1. Nasopharynx swab specimen, non-invasive 2. Very simple to use 3. Convenient, no devices required 4. Rapid, results within 20 minutes 5. Cost-efficient 6:Listed on German BfArm ,got approval by PEI Clinical report from local CDC Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.

The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C). During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.

Covid Ab IgG/IgM Ab Whole blood test device Sensitivity: 86.94% Specificity: 99.31% Accuracy: 93.36%

Bacterial Vaginosis Rapid Test Kit core Chromogenic Ingredient IBX-4041 IBX-4041 Testing vessel BV Blue active ingredient BVBlue active ingredient BVBlue substrates BV Blue substrates Chromogenic substrate IBX-4041 chromogenic substrate of sialidase enzyme Detection reagent for bacterial vaginosis (sialidase two-step method) Shenzhen BST Science & Technology Co., Ltd sells and exports chromogenic substrate of sialidase enzyme IBX-4041. Specification: Appearance: Light yellow solid powder Purity: 95% min Application: Two-step chromogenic substrates of neuraminidase (sialidase) BVBLUE Test Kit Component 1)BVBLUE Developer Solution: Water and Sodium hydroxide 2) BVBLUE Testing Vessel: Water, Potassium acetate, IBX-4041 (chromogenic substrate compound). IBX-4041 is the key ingredient of BVBLUE test kit, BVBLUE test is a rapid sialidase test for bacterial vaginosis. BVBLUE test method is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV), The BV BLUE Test contains a chromogenic substrate of sialidase enzyme, IBX-4041. BV Blue test is a commercially available test, it detects sialidase activity, an enzyme produced by BV-associated bacteria such as Gardnerella vaginalis, Bacteroides spp., Prevotella spp., and Mobiluncus spp. In the test procedure, a vaginal fluid sample is placed in the test vessel which contains a chromogenic substrate for sialidase. After incubation, a developer solution is added, and If the sample contained a high level of sialidase, a blue or green color is seen. Samples containing no sialidase, or low levels of this enzyme, will generate a yellow color in the reaction. The BV test has high specificity and sensitivity. The BVBlue test enables rapid detection of BV in a physician's office, and can thereby provide advantages over the Amsel methods and other methods requiring extensive laboratory testing. Advantage of BVBLUE Test Kit Compared to other diagnostic test methods for BV such as Amsel criteria, Nugent Gram-stain scoring system, Affirm�® Microbial Identification Test, BVBLUE Test Kit has following advantage: 1, BVBLUE Test is currently the only test method approved by the FDA for testing Bacterial Vaginosis(BV). 2, BVBLUE Test just take 10 minutes to 15 minutes to get the result. 3, High purity sialidase substrate with high specificity can reduce the occurrence of false positive. 4. Comparing with the gold standard, the coincidence rate is high, the relative sensitivity is 93%, and the specificity is 95%. 5. Easy to operate, do not need equipment. 6. The specimen does not need to pretreat.

nasal or throat swab, 25 tests per box, it has CE certificate

It has CE certificate, 1T per box, 540 tests per carton; 25T per box, 1000T per carton. high accuracy

25 tests per box, CE certificate

It has CE certificate, 25 tests per box, 40 boxes per carton, high accuracy

For the newly discovered new coronavirus mutant strain Omicron(B.1.1.529),our conducts the sequence comparison analysis of its 32 mutation sites. All mutation sites are outside the epitope region recognized by the new crown paired monoclonal antibody selected by our company.Therefore,according to known academic opinions,the effective production strain for Omicron(B.1.1.529)can still be detected by our product"SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold Immunochromatography)" Next,our will continue to follow up on the mutation of Covid-19perform sequence alignment analysis in timeand evaluate and verify the detection ability of key mutation sites to ensure the sensitivity and specificity of the kit.

ALL OTG PO from Buyer CI from Seller Buyer signs and returns the CI Seller's Attorney prepared LOA and submits to Buyer Escrow Agreement from Seller is signed Buyer escrows funds for full purchase SGS inspection is performed at buyer's expense Logistics details are exchanged Upon confirmed report, escrowed funds are released simultaneous with title transfer

The 2019-nCoV Ag Saliva Rapid Test is a lateral flow immunoassav intended for the qualitative detection of nucleocapsid protein antigen from2019-nCoV in saliva specimens directly collected from individuals who are suspected of COVID-19 by their healthcare provider within the first 7 days of symptom onset

Green Spring Box size: 400 pieces in a box (individual packaging) Size: 70.3*44.9*32.4cm Weight: 15.5kg TGA certification

Box size: 400 pieces in a box (individual packaging) Size: 70.3*44.9*32.4cm Weight: 15.5kg TGA certification